Literature DB >> 22191392

Staphylococcus aureus reservoirs and transmission routes in a Portuguese Neonatal Intensive Care Unit: a 30-month surveillance study.

Teresa Conceição1, Marta Aires de Sousa, Maria Miragaia, Elsa Paulino, Rosalina Barroso, Maria João Brito, Teresa Sardinha, Luísa Sancho, Helena Carreiro, Germano de Sousa, Maria do Céu Machado, Hermínia de Lencastre.   

Abstract

Although Staphylococcus aureus is a major cause of outbreaks in neonatal intensive care units (NICUs), there are no studies on the epidemiology of S. aureus isolates responsible for infection in Portuguese NICUs. Between July 2005 and December 2007, a total of 54 methicillin susceptible S. aureus (MSSA) isolates were recovered from 16 infected infants, parents, health care workers (HCWs), and the environment in a level III NICU. Isolates were characterized by pulsed-field gel electrophoresis (PFGE), spa typing, and multilocus sequence typing. Virulence determinants were detected by multiplex polymerase chain reaction. Three major MSSA clones were endemic in the NICU, representing 70% (n=38) of the isolates: PFGE type A-ST5 (n=17); type B-ST30 (n=12); and type C-ST1 (n=9). Leukotoxins and hemolysins were present in all isolates, although none of them carried PVL. HCWs, plastic folders protecting clinical files, and mothers' nipples were identified as potential reservoirs and/or vehicles of dissemination of S. aureus. Consequently, additional infection control measures were implemented in this NICU.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22191392     DOI: 10.1089/mdr.2011.0182

Source DB:  PubMed          Journal:  Microb Drug Resist        ISSN: 1076-6294            Impact factor:   3.431


  7 in total

1.  The role of breast milk in the colonization of neonatal gut and skin with coagulase-negative staphylococci.

Authors:  Hiie Soeorg; Tuuli Metsvaht; Imbi Eelmäe; Mirjam Merila; Sirli Treumuth; Kristi Huik; Marika Jürna-Ellam; Mari-Liis Ilmoja; Irja Lutsar
Journal:  Pediatr Res       Date:  2017-08-02       Impact factor: 3.756

Review 2.  Potential NICU Environmental Influences on the Neonate's Microbiome: A Systematic Review.

Authors:  Lacey E Hartz; Wanda Bradshaw; Debra H Brandon
Journal:  Adv Neonatal Care       Date:  2015-10       Impact factor: 1.968

3.  Treating Parents to Reduce NICU Transmission of Staphylococcus aureus (TREAT PARENTS) trial: protocol of a multisite randomised, double-blind, placebo-controlled trial.

Authors:  Aaron M Milstone; Danielle W Koontz; Annie Voskertchian; Victor O Popoola; Kathleen Harrelson; Tracy Ross; Susan W Aucott; Maureen M Gilmore; Karen C Carroll; Elizabeth Colantuoni
Journal:  BMJ Open       Date:  2015-09-09       Impact factor: 2.692

4.  Surveillance for Colonization, Transmission, and Infection With Methicillin-Susceptible Staphylococcus aureus in a Neonatal Intensive Care Unit.

Authors:  Dennis Nurjadi; Vanessa M Eichel; Patrik Tabatabai; Sabrina Klein; Katharina Last; Nico T Mutters; Johannes Pöschl; Philipp Zanger; Klaus Heeg; Sébastien Boutin
Journal:  JAMA Netw Open       Date:  2021-09-01

5.  Prevalence and Molecular Epidemiology of Staphylococcus aureus among Residents of Seven Nursing Homes in Shanghai.

Authors:  Ji Zhang; Fei-Fei Gu; Sheng-Yuan Zhao; Shu-Zhen Xiao; Yan-Chun Wang; Xiao-Kui Guo; Yu-Xing Ni; Li-Zhong Han
Journal:  PLoS One       Date:  2015-09-04       Impact factor: 3.240

Review 6.  Gut Microbiome and Infant Health: Brain-Gut-Microbiota Axis and Host Genetic Factors.

Authors:  Xiaomei Cong; Wanli Xu; Rachael Romisher; Samantha Poveda; Shaina Forte; Angela Starkweather; Wendy A Henderson
Journal:  Yale J Biol Med       Date:  2016-09-30

Review 7.  Distribution of the Most Prevalent Spa Types among Clinical Isolates of Methicillin-Resistant and -Susceptible Staphylococcus aureus around the World: A Review.

Authors:  Parisa Asadollahi; Narges Nodeh Farahani; Mehdi Mirzaii; Seyed Sajjad Khoramrooz; Alex van Belkum; Khairollah Asadollahi; Masoud Dadashi; Davood Darban-Sarokhalil
Journal:  Front Microbiol       Date:  2018-02-12       Impact factor: 5.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.